pentobarbital will reduce the extent or result of elbasvir/grazoprevir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. The therapeutic influence of elbasvir/grazoprevir can be reduced if coadministered with strong CYP3A inducers and is as a result contraindicated.… Read More